BREATHLESS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Jul 2024)
What this means for you
Registered since 03 Apr 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86852106
- Registration number
- 5435811
- Mark type
- Stylized text
- Filed
- 17 Dec 2015
- Published for opposition
- 16 Jan 2018
- Registered
- 03 Apr 2018
- Attorney of record
- Scott J. Major
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness of idiopathic pulmonary fibrosis, its symptoms, its prevention and its treatment
- Class 044 — Medical, beauty and agricultural services: Providing medical information regarding idiopathic pulmonary fibrosis, its symptoms, its prevention and its treatment
Owner
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
Prosecution history
- 12 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Jul 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 03 Apr 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Apr 2018 — REGISTERED-PRINCIPAL REGISTER
- 16 Jan 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jan 2018 — PUBLISHED FOR OPPOSITION
- 27 Dec 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Dec 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Nov 2017 — EXPARTE APPEAL TERMINATED
- 27 Nov 2017 — EX PARTE APPEAL-REFUSAL REVERSED
- 24 Aug 2017 — REPLY BRIEF FILED - CHECK TTAB FILES
- 21 Aug 2017 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 21 Aug 2017 — ACTION DENYING REQ FOR RECON E-MAILED